Navigation Links
Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Date:10/18/2007

New Family of Antibacterial Products aimed at reducing cross contamination

infections including MRSA

JACKSONVILLE, Fla., Oct. 18 /PRNewswire/ -- Seal Shield Corporation announced today the SILVER SEAL(TM) family of antibacterial products for infection control. Notably, Seal Shield introduced the SILVER SEAL(TM) Antibacterial, Washable Keyboard and Mouse. According to the company, the SILVER SEAL(TM) Keyboard and Mouse are the first ever antibacterial keyboard and mouse to be fully submersible and dishwasher safe. It has been reported by Dr. William A. Rutala, University of North Carolina that washable keyboards and mice may help reduce the risk of cross contamination infections, including the "superbug," MRSA.

This year over 2 million patients will contract an infection while seeking treatment in a US hospital. Of those, close to 100,000 people will die, making hospital acquired infections a Top 10 killer of Americans. Complicating this epidemic, a strain of antibiotic resistant staph infections, MRSA, has emerged in hospitals, schools and other communal environments worldwide. Seal Shield's products have been developed in response to the demand from healthcare and education organizations for infection control solutions to combat the spread of MRSA and other cross contamination infections.

Recent studies have shown the computer keyboard and mouse to be a major source of cross contamination infections. According to Dr. Daniel LePera, "Bacteria that reside in the upper mouth or respiratory tract can travel to an in-office computer keyboard and survive as long as 24 hours. Viruses can live on them for one hour or more." A study reported at the American Society for Microbiology found that MRSA can survive on computer keyboards for up to 6 weeks.

The recent rise in hospital acquired infections, and the lack of an effective treatment for MRSA, has prompted healthcare providers to reexamine their cleaning protocols in an effort to reduce cross contaminations. In response to the demand from major hospitals, Seal Shield(TM) has developed the SILVER SEAL(TM) family of antibacterial computer input devices which can be disinfected and washed in order to prevent the spread of bacterial infection.

Unlike traditional antibacterial products, the SILVER SEAL(TM) antibacterial plastic utilizes all natural, pure silver ions which are embedded in the plastic to create a safe and effective antibacterial solution. Silver is a natural antibiotic product and its properties have been incorporated into the SILVER SEAL(TM) product line using the latest "nanotechnologies". Silver ions are infused in the plastic used to create the SILVER SEAL(TM) product line. When these ions are exposed to moisture in the air, they create an antimicrobial shield on the product that resists bacteria.

Other "antibacterial" or "antimicrobial" keyboards and mice have proven unreliable because they are manufactured with a chemical coating which can rub off and harm the environment. Additionally, other antibacterial keyboards and mice cannot be washed. Only Seal Shield offers keyboards and mice which are antibacterial and can be fully disinfected, submersed and washed in the dishwasher.

"We know the dangers associated with shared input devices. Studies have shown that computer keyboards and mice are among the primary cross contamination points for the spread of viruses and bacterial infections," states Bradley Whitchurch, Chief Executive Officer at Seal Shield Corporation. "The Seal Shield(TM) product line, introduced earlier this year, addressed this problem by offering the only computer input solutions that could be submersed and washed, even in a dishwasher."

"The new SILVER SEAL(TM) product line is unique," Whitchurch continued. "It offers the same washability of the original Seal Shield(TM) keyboards and mice, but SILVER SEAL(TM) is manufactured with an exclusive, antimicrobial plastic which is resistant to surface bacteria. SILVER SEAL(TM) antibacterial input devices, combined with effective cleaning protocols, represent an effective and economical solution for reducing cross contamination infections. Our products have been designed for healthcare, but are aggressively priced for the mass market," states Whitchurch.

Seal Shield will begin shipping the SILVER SEAL(TM) family of antibacterial products in November '07.

For more information about Seal Shield(TM) infection control products and SILVER SEAL(TM) antibacterial solutions, please visit http://www.SealShield.com

About Seal Shield Corporation

Seal Shield(TM) designs, develops and manufactures medical grade washable computer keyboards and mice for the healthcare and educational industries. For further information and product specifications please visit http://www.SealShield.com/.


'/>"/>
SOURCE Seal Shield Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Protein Found to Shield Pancreatic Cancer Cells from Self-Destruction
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
4. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
5. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
6. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
7. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
8. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
9. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
10. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
11. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient ... bei Brustkrebs   QIAGEN N.V. (NASDAQ: ... gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit ... Assays für die Onkologie eingegangen zu sein. Ein ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... NORTH CHESTERFIELD, Va. , May 25, 2016 ... commercially-available next-generation sequencing test for wounds and infections. ... fungi, ALL parasites, and select viruses. The test ... infected area. David G. ... advanced molecular testing to facilitate wound healing: "We ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media ... Janet Yellen and company to wait until March 2017 for an interest rate increase, ... Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and ... according to court documents and SEC filings. A jury has returned a ... American Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):